Advertisement
New Zealand markets closed

  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     

  • NZD/USD

    0.5941
    -0.0008 (-0.14%)
     

  • NZD/EUR

    0.5549
    +0.0009 (+0.16%)
     

  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     

  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     

  • OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD

    2,349.60
    +7.10 (+0.30%)
     

  • NASDAQ

    17,718.30
    +287.79 (+1.65%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • Dow Jones

    38,239.66
    +153.86 (+0.40%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • NZD/JPY

    94.0360
    +1.5400 (+1.66%)
     

Global DNA Probes-Based Diagnostics Strategic Market Report 2023: World's Aging Population Drives the Popularity of DNA-Probe Tests

Research and Markets
Updated ·4-min read
Company Logo
Company Logo

Global Market for DNA Probes-Based Diagnostics

Global Market for DNA Probes-Based Diagnostics
Global Market for DNA Probes-Based Diagnostics

Dublin, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The "DNA Probes-Based Diagnostics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for DNA Probes-Based Diagnostics estimated at US$14.9 Billion in the year 2022, is projected to reach a revised size of US$31.1 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2022-2030.

Infectious Diseases, one of the segments analyzed in the report, is projected to record a 9.5% CAGR and reach US$18.4 Billion by the end of the analysis period.

ADVERTISEMENT

Taking into account the ongoing post pandemic recovery, growth in the Cancer segment is readjusted to a revised 10.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.4 Billion, While China is Forecast to Grow at 9% CAGR

The DNA Probes-Based Diagnostics market in the U.S. is estimated at US$4.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 9% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.5% and 8.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Select Competitors (Total 46 Featured) -

  • Abbott Molecular

  • Beckman Coulter Inc.

  • Becton, Dickinson and Company

  • bioMerieux

  • F. Hoffmann-La Roche Ltd.

  • GE Healthcare Life Sciences

  • Luminex Corporation

  • QIAGEN N.V.

  • Siemens Healthineers

  • Thermo Fischer Scientific Inc.

What`s New for 2023?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

  • Global competitiveness and key competitor percentage market shares

  • Market presence across multiple geographies - Strong/Active/Niche/Trivial

  • Online interactive peer-to-peer collaborative bespoke updates

  • Access to digital archives and Research Platform

  • Complimentary updates for one year

Report Metrics:

Report Attribute

Details

No. of Pages

193

Forecast Period

2022 - 2030

Estimated Market Value (USD) in 2022

$14.9 Billion

Forecasted Market Value (USD) by 2030

$31.1 Billion

Compound Annual Growth Rate

9.6%

Regions Covered

Global

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • What are DNA-Probes?

  • Recent Market Activity

  • DNA-based Diagnostics - A Prelude

  • DNA Tests: Finding Use in Numerous Applications

  • DNA Probes: Robust Growth Ahead

  • Developed Markets: Traditional Revenue Contributors

  • The United States: Unraveling the Country's Edge in DNA-based Diagnostics

  • Infectious Diseases Tests Dominate the DNA-based Diagnostics Market

  • Developing Countries Excel in Growth Prospects

  • Decoding the Genetic Puzzle

  • Growth Drivers in a Nutshell

  • Growth Inhibitors in a Nutshell

  • Genetic Profiling of Pathogens: A Road Less Traveled

  • Roche's Entry into the Hall of Molecular Fame

  • DNA Technology: An Evolutionary Scan

  • Tracking Landmark Breakthroughs in DNA Diagnostics: 1953-2005

  • Market Opportunities

  • DNA Probes-Based Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)

  • Impact of Covid-19 and a Looming Global Recession

  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • World's Aging Population Drives the Popularity of DNA-Probe Tests

  • Global Aging Population Statistics - Opportunity Indicators

  • Rising Incidence of Chronic Diseases Fuels Demand for DNA Probes Based Diagnostics

  • AIDS: A Global Epidemic

  • Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth

  • Reimbursements: "Under the Umbrella"

  • Evolution of New & Virulent Infectious Agents

  • Challenges in Widespread Deployment of DNA-based Diagnostics

  • DNA Probe Technology Gains Prominence in Diagnosing Vaginitis

  • Gene Banks - A Ray of Hope for the Future

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/yqeg17

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900